Outlook Therapeutics (OTLK) Treasury Shares (2016 - 2024)
Outlook Therapeutics (OTLK) reported Treasury Shares of $123.0 for Q1 2024, down 95.02% year-over-year from $2470.0 in Q2 2023, and down 95.02% quarter-over-quarter from $2470.0 in Q4 2023.
Outlook Therapeutics (OTLK) Treasury Shares (2016 - 2024) Analysis & Trends
Outlook Therapeutics (OTLK) has 9 years of Treasury Shares data on file, last reported at $123.0 in Q1 2024.
- Treasury Shares for Q1 2024 came in at $123.0, down 95.02% year-over-year; the trailing twelve-month figure through Mar 2024 was $123.0 (down 95.02% YoY), and the FY2023 annual result was $123.0, down 95.02% from the prior year.
- Treasury Shares fell to $123.0 in Q1 2024 per OTLK's latest filing, from $2470.0 in the prior quarter.
- Over five years, Treasury Shares peaked at $2470.0 in Q1 2020 and troughed at $123.0 in Q3 2023.
- A 5-year average of $2193.9 and a median of $2470.0 in 2020 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2020 and 2023: Treasury Shares changed 0.0% in 2020, then plunged 95.02% in 2023.
- A 5-year view of Treasury Shares shows it stood at $2470.0 in 2020, then changed by 0.0% to $2470.0 in 2021, then changed by 0.0% to $2470.0 in 2022, then changed by 0.0% to $2470.0 in 2023, then sank by 95.02% to $123.0 in 2024.
- Business Quant data shows OTLK's Treasury Shares at $123.0 in Q1 2024, $2470.0 in Q4 2023, and $123.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Outlook Therapeutics | 51.56 Mn | 43.81 Mn | -21,888.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 123.00 |
| Mar 31, 2024 | 123.00 |
| Dec 31, 2023 | 2,470.00 |
| Dec 31, 2023 | 2,470.00 |
| Sep 30, 2023 | 123.00 |
| Sep 30, 2023 | 123.00 |
| Jun 30, 2023 | 2,470.00 |
| Jun 30, 2023 | 2,470.00 |
| Mar 31, 2023 | 2,470.00 |
| Mar 31, 2023 | 2,470.00 |
| Dec 31, 2022 | 2,470.00 |
| Dec 31, 2022 | 2,470.00 |
| Sep 30, 2022 | 2,470.00 |
| Sep 30, 2022 | 2,470.00 |
| Jun 30, 2022 | 2,470.00 |
| Jun 30, 2022 | 2,470.00 |
| Mar 31, 2022 | 2,470.00 |
| Mar 31, 2022 | 2,470.00 |
| Dec 31, 2021 | 2,470.00 |
| Dec 31, 2021 | 2,470.00 |